← Back to headlines
CVS Health Reintroduces Coverage for Lilly’s Zepbound
CVS Health has reinstated coverage for Eli Lilly's weight-loss drug Zepbound.
28 May, 11:35 — 28 May, 11:35
Sources
Showing 1 of 1 sources
Related Stories
South Korea Central Bank Raises Rates to 3%, Upgrades Growth Forecast
32m ago
Meta Agrees to $17 Billion Settlement Over Teen Mental Health Lawsuits
1h ago
Nvidia in Talks to Acquire AI Platform Hugging Face for Over $13 Billion
1h ago
Mesoblast Reports Strong Revenue Growth Amid Commercial Transition
1h ago